Baseline characteristics of the elderly glioblastoma patient population in British Columbia from 2005 to 2015
Parameter . | Patients, n = 729 . | Patients, % . |
---|---|---|
Sex | ||
Female | 291 | 39.9 |
Male | 438 | 60.1 |
Mean age at diagnosis (range) | 69.7 (60–90) | |
Age at diagnosis | ||
60–64 | 197 | 27.0 |
65–69 | 199 | 27.3 |
70–74 | 145 | 19.9 |
75–79 | 130 | 17.8 |
80–84 | 43 | 5.9 |
85+ | 15 | 2.1 |
Performance score | ||
ECOG 0, 1 | 249 | 34.2 |
ECOG 2 | 237 | 32.5 |
ECOG 3, 4 | 243 | 33.3 |
Diagnosis year, range | ||
2005–2010 | 263 | 36.1 |
2011–2015 | 466 | 63.9 |
Location of lesion | ||
Temporal | 213 | 29.2 |
Frontal | 212 | 29.1 |
Parietal | 147 | 20.2 |
Occipital | 33 | 4.5 |
Multifocala | 24 | 3.3 |
Frontotemporal | 22 | 3.0 |
Frontoparietal | 21 | 2.9 |
Parietooccipital | 16 | 2.2 |
Temporoparietal | 10 | 1.4 |
Temporooccipital | 6 | 0.8 |
Otherb | 25 | 3.4 |
Parameter . | Patients, n = 729 . | Patients, % . |
---|---|---|
Sex | ||
Female | 291 | 39.9 |
Male | 438 | 60.1 |
Mean age at diagnosis (range) | 69.7 (60–90) | |
Age at diagnosis | ||
60–64 | 197 | 27.0 |
65–69 | 199 | 27.3 |
70–74 | 145 | 19.9 |
75–79 | 130 | 17.8 |
80–84 | 43 | 5.9 |
85+ | 15 | 2.1 |
Performance score | ||
ECOG 0, 1 | 249 | 34.2 |
ECOG 2 | 237 | 32.5 |
ECOG 3, 4 | 243 | 33.3 |
Diagnosis year, range | ||
2005–2010 | 263 | 36.1 |
2011–2015 | 466 | 63.9 |
Location of lesion | ||
Temporal | 213 | 29.2 |
Frontal | 212 | 29.1 |
Parietal | 147 | 20.2 |
Occipital | 33 | 4.5 |
Multifocala | 24 | 3.3 |
Frontotemporal | 22 | 3.0 |
Frontoparietal | 21 | 2.9 |
Parietooccipital | 16 | 2.2 |
Temporoparietal | 10 | 1.4 |
Temporooccipital | 6 | 0.8 |
Otherb | 25 | 3.4 |
ECOG, European Cooperative Oncology Group.
aIncludes involvement of more than 2 lobes.
bIncludes lesions in the cerebellum, ventricles, posterior fossa, basal ganglia, brainstem, thalami, insula, and corpus callosum.
Baseline characteristics of the elderly glioblastoma patient population in British Columbia from 2005 to 2015
Parameter . | Patients, n = 729 . | Patients, % . |
---|---|---|
Sex | ||
Female | 291 | 39.9 |
Male | 438 | 60.1 |
Mean age at diagnosis (range) | 69.7 (60–90) | |
Age at diagnosis | ||
60–64 | 197 | 27.0 |
65–69 | 199 | 27.3 |
70–74 | 145 | 19.9 |
75–79 | 130 | 17.8 |
80–84 | 43 | 5.9 |
85+ | 15 | 2.1 |
Performance score | ||
ECOG 0, 1 | 249 | 34.2 |
ECOG 2 | 237 | 32.5 |
ECOG 3, 4 | 243 | 33.3 |
Diagnosis year, range | ||
2005–2010 | 263 | 36.1 |
2011–2015 | 466 | 63.9 |
Location of lesion | ||
Temporal | 213 | 29.2 |
Frontal | 212 | 29.1 |
Parietal | 147 | 20.2 |
Occipital | 33 | 4.5 |
Multifocala | 24 | 3.3 |
Frontotemporal | 22 | 3.0 |
Frontoparietal | 21 | 2.9 |
Parietooccipital | 16 | 2.2 |
Temporoparietal | 10 | 1.4 |
Temporooccipital | 6 | 0.8 |
Otherb | 25 | 3.4 |
Parameter . | Patients, n = 729 . | Patients, % . |
---|---|---|
Sex | ||
Female | 291 | 39.9 |
Male | 438 | 60.1 |
Mean age at diagnosis (range) | 69.7 (60–90) | |
Age at diagnosis | ||
60–64 | 197 | 27.0 |
65–69 | 199 | 27.3 |
70–74 | 145 | 19.9 |
75–79 | 130 | 17.8 |
80–84 | 43 | 5.9 |
85+ | 15 | 2.1 |
Performance score | ||
ECOG 0, 1 | 249 | 34.2 |
ECOG 2 | 237 | 32.5 |
ECOG 3, 4 | 243 | 33.3 |
Diagnosis year, range | ||
2005–2010 | 263 | 36.1 |
2011–2015 | 466 | 63.9 |
Location of lesion | ||
Temporal | 213 | 29.2 |
Frontal | 212 | 29.1 |
Parietal | 147 | 20.2 |
Occipital | 33 | 4.5 |
Multifocala | 24 | 3.3 |
Frontotemporal | 22 | 3.0 |
Frontoparietal | 21 | 2.9 |
Parietooccipital | 16 | 2.2 |
Temporoparietal | 10 | 1.4 |
Temporooccipital | 6 | 0.8 |
Otherb | 25 | 3.4 |
ECOG, European Cooperative Oncology Group.
aIncludes involvement of more than 2 lobes.
bIncludes lesions in the cerebellum, ventricles, posterior fossa, basal ganglia, brainstem, thalami, insula, and corpus callosum.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.